David McWilliams

Président chez GREENWICH LIFESCIENCES, INC. Fortune : 16 M $ au 31/05/2026

Profil

David B. McWilliams is currently Chairman at BioHouston, Inc. and Greenwich LifeSciences, Inc. (since 2016), Director at Texas Healthcare & Bioscience Institute and Norwell Mfg.
Co., Inc., and Member of The Phi Beta Kappa Society.
Former roles include President, Chief Executive Officer & Director at Encysive Pharmaceuticals, Inc. (1992–2002); Chief Executive Officer & Director at Signase, Inc.; President & Chief Executive Officer at Bacterial Barcodes, Inc. (2003); President & Chief Executive Officer at Opexa Therapeutics, Inc. (2006–2008); President & Chief Executive Officer at Kallestad Diagnostics, Inc.; Director at Repros Therapeutics, Inc.; Director at Novelos Therapeutics, Inc. (2005–2011); Director at Technology & Entrepreneurship Center of Houston; Director at ApoCell, Inc.; General Manager at Abbott Laboratories; Management Consultant at McKinsey & Co., Inc.; and President-Harleco Diagnostics Division at EM Industries LLC.
Education includes an MBA from The University of Chicago and undergraduate studies at Washington & Jefferson College.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GREENWICH LIFESCIENCES, INC. 4,48 %	26/05/2026	620 328 ( 4,48 % )	16 M $	31/05/2026

Postes actifs de David McWilliams

Sociétés	Poste	Début
GREENWICH LIFESCIENCES, INC.	Président	01/02/2009
BioHouston, Inc.	Président	-
Norwell Mfg. Co., Inc.	Directeur/Membre du Conseil	-
The Phi Beta Kappa Society	Corporate Officer/Principal	-
Texas Healthcare & Bioscience Institute	Directeur/Membre du Conseil	-

Anciens postes connus de David McWilliams

Sociétés	Poste	Fin
Novelos Therapeutics, Inc.	Directeur/Membre du Conseil	08/04/2011
Opexa Therapeutics, Inc.	Directeur Général	01/06/2008
Bacterial Barcodes, Inc.	Directeur Général	01/12/2003
Encysive Pharmaceuticals, Inc.	Directeur Général	25/03/2002
░░ ░░░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-